Armistice Capital’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-50,000
| Closed | -$24.2M | – | 269 |
|
|
2025
Q1 | $24.2M | Sell |
50,000
-174,016
| -78% | -$84.4M | 0.36% | 53 |
|
|
2024
Q4 | $90.2M | Buy |
224,016
+177,887
| +386% | +$71.6M | 1.23% | 8 |
|
|
2024
Q3 | $21.5M | Buy |
46,129
+10,070
| +28% | +$4.68M | 0.34% | 48 |
|
|
2024
Q2 | $16.9M | Sell |
36,059
-15,921
| -31% | -$7.46M | 0.21% | 71 |
|
|
2024
Q1 | $21.7M | Sell |
51,980
-46,020
| -47% | -$19.2M | 0.29% | 60 |
|
|
2023
Q4 | $39.9M | Sell |
98,000
-18,117
| -16% | -$7.37M | 0.54% | 31 |
|
|
2023
Q3 | $40.4M | Sell |
116,117
-7,883
| -6% | -$2.74M | 0.62% | 29 |
|
|
2023
Q2 | $43.6M | Sell |
124,000
-96,000
| -44% | -$33.8M | 0.63% | 31 |
|
|
2023
Q1 | $69.3M | Buy |
220,000
+72,000
| +49% | +$22.7M | 1% | 22 |
|
|
2022
Q4 | $42.7M | Sell |
148,000
-2,000
| -1% | -$578K | 0.75% | 29 |
|
|
2022
Q3 | $43.4M | Sell |
150,000
-162,000
| -52% | -$46.9M | 0.75% | 32 |
|
|
2022
Q2 | $87.9K | Buy |
312,000
+76,000
| +32% | +$21.4K | 1.53% | 13 |
|
|
2022
Q1 | $61.6M | Sell |
236,000
-252,000
| -52% | -$65.8M | 1.19% | 22 |
|
|
2021
Q4 | $107M | Sell |
488,000
-148,000
| -23% | -$32.5M | 1.75% | 8 |
|
|
2021
Q3 | $115M | Buy |
636,000
+36,000
| +6% | +$6.53M | 1.95% | 4 |
|
|
2021
Q2 | $121M | Buy |
600,000
+208,000
| +53% | +$41.9M | 2.17% | 3 |
|
|
2021
Q1 | $84.2M | Buy |
+392,000
| New | +$84.2M | 1.93% | 5 |
|
|
2020
Q1 | – | Sell |
-65,000
| Closed | -$14.2M | – | 100 |
|
|
2019
Q4 | $14.2M | Buy |
65,000
+35,000
| +117% | +$7.66M | 0.82% | 36 |
|
|
2019
Q3 | $5.08M | Buy |
+30,000
| New | +$5.08M | 0.34% | 47 |
|